PreAsthmaControl (PAC)

NCT00234390 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Pulmicort (budesonide) pMDI

Sponsor

AstraZeneca